Fluidigm Prices IPO at $13.50 per Share
February 10, 2011
Fluidigm Prices IPO at $13.50 per Share
The 5.6 million shares offering will bring in gross proceeds of $75 million.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Fluidigm Underwriters Exercise Over-allotment Option
February 16, 2011 / GenomeWeb Daily News - Fluidigm Sets IPO Pricing at $13.50 per Share
February 10, 2011 / PCR Insider - Fluidigm Places Price Range of $13.50 to $15.50 per Share on IPO
January 28, 2011 / GenomeWeb Daily News - Saskatchewan Disease Control Lab to Use Fluidigm BioMark in Infectious Disease Testing
May 9, 2013 / PCR Insider - Single-cell Genomics Continues to Drive Growth at Fluidigm as Q1 Revenues Rise 33 Percent
May 2, 2013 / PCR Insider